
<!doctype html>
<html lang="en" class="no-js">
  <head>
    
      <meta charset="utf-8">
      <meta name="viewport" content="width=device-width,initial-scale=1">
      
        <meta name="description" content="Evidence-based clinical decision support templates for neurological diagnoses">
      
      
      
        <link rel="canonical" href="https://blondarb.github.io/neuro-plans/plans/hsv-encephalitis/">
      
      
        <link rel="prev" href="../bacterial-meningitis/">
      
      
        <link rel="next" href="../autoimmune-encephalitis/">
      
      
        
      
      
      <link rel="icon" href="../../assets/images/favicon.png">
      <meta name="generator" content="mkdocs-1.6.1, mkdocs-material-9.7.1">
    
    
      
        <title>HSV Encephalitis - Neuro Clinical Plans</title>
      
    
    
      <link rel="stylesheet" href="../../assets/stylesheets/main.484c7ddc.min.css">
      
        
        <link rel="stylesheet" href="../../assets/stylesheets/palette.ab4e12ef.min.css">
      
      


    
    
      
    
    
      
        
        
        <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
        <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:300,300i,400,400i,700,700i%7CRoboto+Mono:400,400i,700,700i&display=fallback">
        <style>:root{--md-text-font:"Roboto";--md-code-font:"Roboto Mono"}</style>
      
    
    
      <link rel="stylesheet" href="../../assets/css/custom.css">
    
    <script>__md_scope=new URL("../..",location),__md_hash=e=>[...e].reduce(((e,_)=>(e<<5)-e+_.charCodeAt(0)),0),__md_get=(e,_=localStorage,t=__md_scope)=>JSON.parse(_.getItem(t.pathname+"."+e)),__md_set=(e,_,t=localStorage,a=__md_scope)=>{try{t.setItem(a.pathname+"."+e,JSON.stringify(_))}catch(e){}}</script>
    
      

    
    
  </head>
  
  
    
    
      
    
    
    
    
    <body dir="ltr" data-md-color-scheme="default" data-md-color-primary="indigo" data-md-color-accent="indigo">
  
    
    <input class="md-toggle" data-md-toggle="drawer" type="checkbox" id="__drawer" autocomplete="off">
    <input class="md-toggle" data-md-toggle="search" type="checkbox" id="__search" autocomplete="off">
    <label class="md-overlay" for="__drawer"></label>
    <div data-md-component="skip">
      
        
        <a href="#hsv-encephalitis" class="md-skip">
          Skip to content
        </a>
      
    </div>
    <div data-md-component="announce">
      
    </div>
    
    
      

  

<header class="md-header md-header--shadow" data-md-component="header">
  <nav class="md-header__inner md-grid" aria-label="Header">
    <a href="../.." title="Neuro Clinical Plans" class="md-header__button md-logo" aria-label="Neuro Clinical Plans" data-md-component="logo">
      
  
  <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M12 8a3 3 0 0 0 3-3 3 3 0 0 0-3-3 3 3 0 0 0-3 3 3 3 0 0 0 3 3m0 3.54C9.64 9.35 6.5 8 3 8v11c3.5 0 6.64 1.35 9 3.54 2.36-2.19 5.5-3.54 9-3.54V8c-3.5 0-6.64 1.35-9 3.54"/></svg>

    </a>
    <label class="md-header__button md-icon" for="__drawer">
      
      <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M3 6h18v2H3zm0 5h18v2H3zm0 5h18v2H3z"/></svg>
    </label>
    <div class="md-header__title" data-md-component="header-title">
      <div class="md-header__ellipsis">
        <div class="md-header__topic">
          <span class="md-ellipsis">
            Neuro Clinical Plans
          </span>
        </div>
        <div class="md-header__topic" data-md-component="header-topic">
          <span class="md-ellipsis">
            
              HSV Encephalitis
            
          </span>
        </div>
      </div>
    </div>
    
      
        <form class="md-header__option" data-md-component="palette">
  
    
    
    
    <input class="md-option" data-md-color-media="" data-md-color-scheme="default" data-md-color-primary="indigo" data-md-color-accent="indigo"  aria-label="Switch to dark mode"  type="radio" name="__palette" id="__palette_0">
    
      <label class="md-header__button md-icon" title="Switch to dark mode" for="__palette_1" hidden>
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M12 8a4 4 0 0 0-4 4 4 4 0 0 0 4 4 4 4 0 0 0 4-4 4 4 0 0 0-4-4m0 10a6 6 0 0 1-6-6 6 6 0 0 1 6-6 6 6 0 0 1 6 6 6 6 0 0 1-6 6m8-9.31V4h-4.69L12 .69 8.69 4H4v4.69L.69 12 4 15.31V20h4.69L12 23.31 15.31 20H20v-4.69L23.31 12z"/></svg>
      </label>
    
  
    
    
    
    <input class="md-option" data-md-color-media="" data-md-color-scheme="slate" data-md-color-primary="indigo" data-md-color-accent="indigo"  aria-label="Switch to light mode"  type="radio" name="__palette" id="__palette_1">
    
      <label class="md-header__button md-icon" title="Switch to light mode" for="__palette_0" hidden>
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M12 18c-.89 0-1.74-.2-2.5-.55C11.56 16.5 13 14.42 13 12s-1.44-4.5-3.5-5.45C10.26 6.2 11.11 6 12 6a6 6 0 0 1 6 6 6 6 0 0 1-6 6m8-9.31V4h-4.69L12 .69 8.69 4H4v4.69L.69 12 4 15.31V20h4.69L12 23.31 15.31 20H20v-4.69L23.31 12z"/></svg>
      </label>
    
  
</form>
      
    
    
      <script>var palette=__md_get("__palette");if(palette&&palette.color){if("(prefers-color-scheme)"===palette.color.media){var media=matchMedia("(prefers-color-scheme: light)"),input=document.querySelector(media.matches?"[data-md-color-media='(prefers-color-scheme: light)']":"[data-md-color-media='(prefers-color-scheme: dark)']");palette.color.media=input.getAttribute("data-md-color-media"),palette.color.scheme=input.getAttribute("data-md-color-scheme"),palette.color.primary=input.getAttribute("data-md-color-primary"),palette.color.accent=input.getAttribute("data-md-color-accent")}for(var[key,value]of Object.entries(palette.color))document.body.setAttribute("data-md-color-"+key,value)}</script>
    
    
    
      
      
        <label class="md-header__button md-icon" for="__search">
          
          <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.52 6.52 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5"/></svg>
        </label>
        <div class="md-search" data-md-component="search" role="dialog">
  <label class="md-search__overlay" for="__search"></label>
  <div class="md-search__inner" role="search">
    <form class="md-search__form" name="search">
      <input type="text" class="md-search__input" name="query" aria-label="Search" placeholder="Search" autocapitalize="off" autocorrect="off" autocomplete="off" spellcheck="false" data-md-component="search-query" required>
      <label class="md-search__icon md-icon" for="__search">
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M9.5 3A6.5 6.5 0 0 1 16 9.5c0 1.61-.59 3.09-1.56 4.23l.27.27h.79l5 5-1.5 1.5-5-5v-.79l-.27-.27A6.52 6.52 0 0 1 9.5 16 6.5 6.5 0 0 1 3 9.5 6.5 6.5 0 0 1 9.5 3m0 2C7 5 5 7 5 9.5S7 14 9.5 14 14 12 14 9.5 12 5 9.5 5"/></svg>
        
        <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M20 11v2H8l5.5 5.5-1.42 1.42L4.16 12l7.92-7.92L13.5 5.5 8 11z"/></svg>
      </label>
      <nav class="md-search__options" aria-label="Search">
        
        <button type="reset" class="md-search__icon md-icon" title="Clear" aria-label="Clear" tabindex="-1">
          
          <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M19 6.41 17.59 5 12 10.59 6.41 5 5 6.41 10.59 12 5 17.59 6.41 19 12 13.41 17.59 19 19 17.59 13.41 12z"/></svg>
        </button>
      </nav>
      
        <div class="md-search__suggest" data-md-component="search-suggest"></div>
      
    </form>
    <div class="md-search__output">
      <div class="md-search__scrollwrap" tabindex="0" data-md-scrollfix>
        <div class="md-search-result" data-md-component="search-result">
          <div class="md-search-result__meta">
            Initializing search
          </div>
          <ol class="md-search-result__list" role="presentation"></ol>
        </div>
      </div>
    </div>
  </div>
</div>
      
    
    
      <div class="md-header__source">
        <a href="https://github.com/blondarb/neuro-plans" title="Go to repository" class="md-source" data-md-component="source">
  <div class="md-source__icon md-icon">
    
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Free 7.1.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2025 Fonticons, Inc.--><path d="M173.9 397.4c0 2-2.3 3.6-5.2 3.6-3.3.3-5.6-1.3-5.6-3.6 0-2 2.3-3.6 5.2-3.6 3-.3 5.6 1.3 5.6 3.6m-31.1-4.5c-.7 2 1.3 4.3 4.3 4.9 2.6 1 5.6 0 6.2-2s-1.3-4.3-4.3-5.2c-2.6-.7-5.5.3-6.2 2.3m44.2-1.7c-2.9.7-4.9 2.6-4.6 4.9.3 2 2.9 3.3 5.9 2.6 2.9-.7 4.9-2.6 4.6-4.6-.3-1.9-3-3.2-5.9-2.9M252.8 8C114.1 8 8 113.3 8 252c0 110.9 69.8 205.8 169.5 239.2 12.8 2.3 17.3-5.6 17.3-12.1 0-6.2-.3-40.4-.3-61.4 0 0-70 15-84.7-29.8 0 0-11.4-29.1-27.8-36.6 0 0-22.9-15.7 1.6-15.4 0 0 24.9 2 38.6 25.8 21.9 38.6 58.6 27.5 72.9 20.9 2.3-16 8.8-27.1 16-33.7-55.9-6.2-112.3-14.3-112.3-110.5 0-27.5 7.6-41.3 23.6-58.9-2.6-6.5-11.1-33.3 2.6-67.9 20.9-6.5 69 27 69 27 20-5.6 41.5-8.5 62.8-8.5s42.8 2.9 62.8 8.5c0 0 48.1-33.6 69-27 13.7 34.7 5.2 61.4 2.6 67.9 16 17.7 25.8 31.5 25.8 58.9 0 96.5-58.9 104.2-114.8 110.5 9.2 7.9 17 22.9 17 46.4 0 33.7-.3 75.4-.3 83.6 0 6.5 4.6 14.4 17.3 12.1C436.2 457.8 504 362.9 504 252 504 113.3 391.5 8 252.8 8M105.2 352.9c-1.3 1-1 3.3.7 5.2 1.6 1.6 3.9 2.3 5.2 1 1.3-1 1-3.3-.7-5.2-1.6-1.6-3.9-2.3-5.2-1m-10.8-8.1c-.7 1.3.3 2.9 2.3 3.9 1.6 1 3.6.7 4.3-.7.7-1.3-.3-2.9-2.3-3.9-2-.6-3.6-.3-4.3.7m32.4 35.6c-1.6 1.3-1 4.3 1.3 6.2 2.3 2.3 5.2 2.6 6.5 1 1.3-1.3.7-4.3-1.3-6.2-2.2-2.3-5.2-2.6-6.5-1m-11.4-14.7c-1.6 1-1.6 3.6 0 5.9s4.3 3.3 5.6 2.3c1.6-1.3 1.6-3.9 0-6.2-1.4-2.3-4-3.3-5.6-2"/></svg>
  </div>
  <div class="md-source__repository">
    blondarb/neuro-plans
  </div>
</a>
      </div>
    
  </nav>
  
</header>
    
    <div class="md-container" data-md-component="container">
      
      
        
          
        
      
      <main class="md-main" data-md-component="main">
        <div class="md-main__inner md-grid">
          
            
              
              <div class="md-sidebar md-sidebar--primary" data-md-component="sidebar" data-md-type="navigation" >
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    



<nav class="md-nav md-nav--primary" aria-label="Navigation" data-md-level="0">
  <label class="md-nav__title" for="__drawer">
    <a href="../.." title="Neuro Clinical Plans" class="md-nav__button md-logo" aria-label="Neuro Clinical Plans" data-md-component="logo">
      
  
  <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M12 8a3 3 0 0 0 3-3 3 3 0 0 0-3-3 3 3 0 0 0-3 3 3 3 0 0 0 3 3m0 3.54C9.64 9.35 6.5 8 3 8v11c3.5 0 6.64 1.35 9 3.54 2.36-2.19 5.5-3.54 9-3.54V8c-3.5 0-6.64 1.35-9 3.54"/></svg>

    </a>
    Neuro Clinical Plans
  </label>
  
    <div class="md-nav__source">
      <a href="https://github.com/blondarb/neuro-plans" title="Go to repository" class="md-source" data-md-component="source">
  <div class="md-source__icon md-icon">
    
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Free 7.1.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2025 Fonticons, Inc.--><path d="M173.9 397.4c0 2-2.3 3.6-5.2 3.6-3.3.3-5.6-1.3-5.6-3.6 0-2 2.3-3.6 5.2-3.6 3-.3 5.6 1.3 5.6 3.6m-31.1-4.5c-.7 2 1.3 4.3 4.3 4.9 2.6 1 5.6 0 6.2-2s-1.3-4.3-4.3-5.2c-2.6-.7-5.5.3-6.2 2.3m44.2-1.7c-2.9.7-4.9 2.6-4.6 4.9.3 2 2.9 3.3 5.9 2.6 2.9-.7 4.9-2.6 4.6-4.6-.3-1.9-3-3.2-5.9-2.9M252.8 8C114.1 8 8 113.3 8 252c0 110.9 69.8 205.8 169.5 239.2 12.8 2.3 17.3-5.6 17.3-12.1 0-6.2-.3-40.4-.3-61.4 0 0-70 15-84.7-29.8 0 0-11.4-29.1-27.8-36.6 0 0-22.9-15.7 1.6-15.4 0 0 24.9 2 38.6 25.8 21.9 38.6 58.6 27.5 72.9 20.9 2.3-16 8.8-27.1 16-33.7-55.9-6.2-112.3-14.3-112.3-110.5 0-27.5 7.6-41.3 23.6-58.9-2.6-6.5-11.1-33.3 2.6-67.9 20.9-6.5 69 27 69 27 20-5.6 41.5-8.5 62.8-8.5s42.8 2.9 62.8 8.5c0 0 48.1-33.6 69-27 13.7 34.7 5.2 61.4 2.6 67.9 16 17.7 25.8 31.5 25.8 58.9 0 96.5-58.9 104.2-114.8 110.5 9.2 7.9 17 22.9 17 46.4 0 33.7-.3 75.4-.3 83.6 0 6.5 4.6 14.4 17.3 12.1C436.2 457.8 504 362.9 504 252 504 113.3 391.5 8 252.8 8M105.2 352.9c-1.3 1-1 3.3.7 5.2 1.6 1.6 3.9 2.3 5.2 1 1.3-1 1-3.3-.7-5.2-1.6-1.6-3.9-2.3-5.2-1m-10.8-8.1c-.7 1.3.3 2.9 2.3 3.9 1.6 1 3.6.7 4.3-.7.7-1.3-.3-2.9-2.3-3.9-2-.6-3.6-.3-4.3.7m32.4 35.6c-1.6 1.3-1 4.3 1.3 6.2 2.3 2.3 5.2 2.6 6.5 1 1.3-1.3.7-4.3-1.3-6.2-2.2-2.3-5.2-2.6-6.5-1m-11.4-14.7c-1.6 1-1.6 3.6 0 5.9s4.3 3.3 5.6 2.3c1.6-1.3 1.6-3.9 0-6.2-1.4-2.3-4-3.3-5.6-2"/></svg>
  </div>
  <div class="md-source__repository">
    blondarb/neuro-plans
  </div>
</a>
    </div>
  
  <ul class="md-nav__list" data-md-scrollfix>
    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href="../.." class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Home
  

    
  </span>
  
  

      </a>
    </li>
  

    
      
      
  
  
  
  
    <li class="md-nav__item">
      <a href="../../clinical/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Interactive Clinical Tool
  

    
  </span>
  
  

      </a>
    </li>
  

    
      
      
  
  
    
  
  
  
    
    
    
    
      
        
        
      
    
    
    <li class="md-nav__item md-nav__item--active md-nav__item--section md-nav__item--nested">
      
        
        
        <input class="md-nav__toggle md-toggle " type="checkbox" id="__nav_3" checked>
        
          
          <label class="md-nav__link" for="__nav_3" id="__nav_3_label" tabindex="">
            
  
  
  <span class="md-ellipsis">
    
  
    Clinical Plans
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="1" aria-labelledby="__nav_3_label" aria-expanded="true">
          <label class="md-nav__title" for="__nav_3">
            <span class="md-nav__icon md-icon"></span>
            
  
    Clinical Plans
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Overview
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_2" >
        
          
          <label class="md-nav__link" for="__nav_3_2" id="__nav_3_2_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Seizures & Epilepsy
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_2_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_2">
            <span class="md-nav__icon md-icon"></span>
            
  
    Seizures & Epilepsy
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../status-epilepticus/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Status Epilepticus
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../new-onset-seizure/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    New Onset Seizure
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../breakthrough-seizure/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Breakthrough Seizure
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_3" >
        
          
          <label class="md-nav__link" for="__nav_3_3" id="__nav_3_3_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Stroke & Vascular
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_3_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_3">
            <span class="md-nav__icon md-icon"></span>
            
  
    Stroke & Vascular
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../acute-ischemic-stroke/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Acute Ischemic Stroke
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../transient-ischemic-attack/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Transient Ischemic Attack
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../intracerebral-hemorrhage/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Intracerebral Hemorrhage
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../subarachnoid-hemorrhage/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Subarachnoid Hemorrhage
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_4" >
        
          
          <label class="md-nav__link" for="__nav_3_4" id="__nav_3_4_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Neuromuscular
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_4_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_4">
            <span class="md-nav__icon md-icon"></span>
            
  
    Neuromuscular
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../guillain-barre-syndrome/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Guillain-Barré Syndrome
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../myasthenia-gravis-crisis/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Myasthenic Crisis
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../myasthenia-gravis-new-diagnosis/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Myasthenia Gravis - New Diagnosis
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../neuromuscular-respiratory-failure/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Neuromuscular Respiratory Failure
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../peripheral-neuropathy/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Peripheral Neuropathy
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
    
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--active md-nav__item--nested">
      
        
        
        <input class="md-nav__toggle md-toggle " type="checkbox" id="__nav_3_5" checked>
        
          
          <label class="md-nav__link" for="__nav_3_5" id="__nav_3_5_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    CNS Infections
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_5_label" aria-expanded="true">
          <label class="md-nav__title" for="__nav_3_5">
            <span class="md-nav__icon md-icon"></span>
            
  
    CNS Infections
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../bacterial-meningitis/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Bacterial Meningitis
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
    
  
  
  
    <li class="md-nav__item md-nav__item--active">
      
      <input class="md-nav__toggle md-toggle" type="checkbox" id="__toc">
      
      
        
      
      
        <label class="md-nav__link md-nav__link--active" for="__toc">
          
  
  
  <span class="md-ellipsis">
    
  
    HSV Encephalitis
  

    
  </span>
  
  

          <span class="md-nav__icon md-icon"></span>
        </label>
      
      <a href="./" class="md-nav__link md-nav__link--active">
        
  
  
  <span class="md-ellipsis">
    
  
    HSV Encephalitis
  

    
  </span>
  
  

      </a>
      
        

<nav class="md-nav md-nav--secondary" aria-label="Table of contents">
  
  
  
    
  
  
    <label class="md-nav__title" for="__toc">
      <span class="md-nav__icon md-icon"></span>
      Table of contents
    </label>
    <ul class="md-nav__list" data-md-component="toc" data-md-scrollfix>
      
        <li class="md-nav__item">
  <a href="#1-laboratory-workup" class="md-nav__link">
    <span class="md-ellipsis">
      
        1. LABORATORY WORKUP
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#2-diagnostic-imaging-studies" class="md-nav__link">
    <span class="md-ellipsis">
      
        2. DIAGNOSTIC IMAGING &amp; STUDIES
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#3-treatment" class="md-nav__link">
    <span class="md-ellipsis">
      
        3. TREATMENT
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#4-other-recommendations" class="md-nav__link">
    <span class="md-ellipsis">
      
        4. OTHER RECOMMENDATIONS
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#5-differential-diagnosis" class="md-nav__link">
    <span class="md-ellipsis">
      
        5. DIFFERENTIAL DIAGNOSIS
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#6-monitoring-parameters" class="md-nav__link">
    <span class="md-ellipsis">
      
        6. MONITORING PARAMETERS
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#7-disposition-criteria" class="md-nav__link">
    <span class="md-ellipsis">
      
        7. DISPOSITION CRITERIA
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#8-evidence-references" class="md-nav__link">
    <span class="md-ellipsis">
      
        8. EVIDENCE &amp; REFERENCES
      
    </span>
  </a>
  
</li>
      
    </ul>
  
</nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../autoimmune-encephalitis/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Autoimmune Encephalitis
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_6" >
        
          
          <label class="md-nav__link" for="__nav_3_6" id="__nav_3_6_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Spinal Emergencies
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_6_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_6">
            <span class="md-nav__icon md-icon"></span>
            
  
    Spinal Emergencies
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../acute-myelopathy/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Acute Myelopathy
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../spinal-cord-compression-malignant/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Spinal Cord Compression (Malignant)
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../cauda-equina-syndrome/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Cauda Equina Syndrome
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../epidural-abscess/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Epidural Abscess
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_7" >
        
          
          <label class="md-nav__link" for="__nav_3_7" id="__nav_3_7_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Neuro-Oncology
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_7_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_7">
            <span class="md-nav__icon md-icon"></span>
            
  
    Neuro-Oncology
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../brain-metastases/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Brain Metastases
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_8" >
        
          
          <label class="md-nav__link" for="__nav_3_8" id="__nav_3_8_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Critical Care
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_8_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_8">
            <span class="md-nav__icon md-icon"></span>
            
  
    Critical Care
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../elevated-icp-management/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Elevated ICP Management
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_9" >
        
          
          <label class="md-nav__link" for="__nav_3_9" id="__nav_3_9_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Demyelinating
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_9_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_9">
            <span class="md-nav__icon md-icon"></span>
            
  
    Demyelinating
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../ms-new-diagnosis/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    MS New Diagnosis
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
              
                
  
  
  
  
    
    
    
    
      
    
    
    <li class="md-nav__item md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_3_10" >
        
          
          <label class="md-nav__link" for="__nav_3_10" id="__nav_3_10_label" tabindex="0">
            
  
  
  <span class="md-ellipsis">
    
  
    Other
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="2" aria-labelledby="__nav_3_10_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_3_10">
            <span class="md-nav__icon md-icon"></span>
            
  
    Other
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../rapidly-progressive-dementia/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Rapidly Progressive Dementia
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../vertigo-dizziness-evaluation/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Vertigo / Dizziness
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

    
      
      
  
  
  
  
    
    
    
    
      
        
        
      
    
    
    <li class="md-nav__item md-nav__item--section md-nav__item--nested">
      
        
        
          
        
        <input class="md-nav__toggle md-toggle md-toggle--indeterminate" type="checkbox" id="__nav_4" >
        
          
          <label class="md-nav__link" for="__nav_4" id="__nav_4_label" tabindex="">
            
  
  
  <span class="md-ellipsis">
    
  
    References
  

    
  </span>
  
  

            <span class="md-nav__icon md-icon"></span>
          </label>
        
        <nav class="md-nav" data-md-level="1" aria-labelledby="__nav_4_label" aria-expanded="false">
          <label class="md-nav__title" for="__nav_4">
            <span class="md-nav__icon md-icon"></span>
            
  
    References
  

          </label>
          <ul class="md-nav__list" data-md-scrollfix>
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../references/lp-reference/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    LP Reference
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
              
                
  
  
  
  
    <li class="md-nav__item">
      <a href="../../references/tracker/" class="md-nav__link">
        
  
  
  <span class="md-ellipsis">
    
  
    Template Tracker
  

    
  </span>
  
  

      </a>
    </li>
  

              
            
          </ul>
        </nav>
      
    </li>
  

    
  </ul>
</nav>
                  </div>
                </div>
              </div>
            
            
              
              <div class="md-sidebar md-sidebar--secondary" data-md-component="sidebar" data-md-type="toc" >
                <div class="md-sidebar__scrollwrap">
                  <div class="md-sidebar__inner">
                    

<nav class="md-nav md-nav--secondary" aria-label="Table of contents">
  
  
  
    
  
  
    <label class="md-nav__title" for="__toc">
      <span class="md-nav__icon md-icon"></span>
      Table of contents
    </label>
    <ul class="md-nav__list" data-md-component="toc" data-md-scrollfix>
      
        <li class="md-nav__item">
  <a href="#1-laboratory-workup" class="md-nav__link">
    <span class="md-ellipsis">
      
        1. LABORATORY WORKUP
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#2-diagnostic-imaging-studies" class="md-nav__link">
    <span class="md-ellipsis">
      
        2. DIAGNOSTIC IMAGING &amp; STUDIES
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#3-treatment" class="md-nav__link">
    <span class="md-ellipsis">
      
        3. TREATMENT
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#4-other-recommendations" class="md-nav__link">
    <span class="md-ellipsis">
      
        4. OTHER RECOMMENDATIONS
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#5-differential-diagnosis" class="md-nav__link">
    <span class="md-ellipsis">
      
        5. DIFFERENTIAL DIAGNOSIS
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#6-monitoring-parameters" class="md-nav__link">
    <span class="md-ellipsis">
      
        6. MONITORING PARAMETERS
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#7-disposition-criteria" class="md-nav__link">
    <span class="md-ellipsis">
      
        7. DISPOSITION CRITERIA
      
    </span>
  </a>
  
</li>
      
        <li class="md-nav__item">
  <a href="#8-evidence-references" class="md-nav__link">
    <span class="md-ellipsis">
      
        8. EVIDENCE &amp; REFERENCES
      
    </span>
  </a>
  
</li>
      
    </ul>
  
</nav>
                  </div>
                </div>
              </div>
            
          
          
            <div class="md-content" data-md-component="content">
              
              <article class="md-content__inner md-typeset">
                
                  


  
  


<h1 id="hsv-encephalitis">HSV Encephalitis<a class="headerlink" href="#hsv-encephalitis" title="Permanent link">&para;</a></h1>
<p><strong>VERSION:</strong> 1.0
<strong>CREATED:</strong> January 27, 2026
<strong>STATUS:</strong> Initial build</p>
<hr />
<p><strong>DIAGNOSIS:</strong> Herpes Simplex Virus Encephalitis</p>
<p><strong>ICD-10:</strong> B00.4 (Herpesviral encephalitis), G05.1 (Encephalitis in diseases classified elsewhere)</p>
<p><strong>SYNONYMS:</strong> HSV encephalitis, herpes encephalitis, herpes simplex encephalitis, viral encephalitis, limbic encephalitis, temporal lobe encephalitis, brain infection, encephalitis</p>
<p><strong>SCOPE:</strong> Acute HSV-1 encephalitis in adults — the most common cause of sporadic fatal encephalitis. Covers emergent empiric acyclovir, LP with HSV PCR, MRI findings, seizure management, and monitoring for complications (cerebral edema, SIADH, refractory status epilepticus). Excludes neonatal HSV, HSV-2 meningitis (Mollaret), CMV/EBV/VZV encephalitis, and autoimmune encephalitis (though post-HSV autoimmune encephalitis is addressed).</p>
<hr />
<p><strong>PRIORITY KEY:</strong> STAT = Immediate | URGENT = Within hours | ROUTINE = Standard | EXT = Extended/atypical cases | - = Not applicable to this setting</p>
<p>═══════════════════════════════════════════════════════════════
SECTION A: ACTION ITEMS
═══════════════════════════════════════════════════════════════</p>
<h2 id="1-laboratory-workup">1. LABORATORY WORKUP<a class="headerlink" href="#1-laboratory-workup" title="Permanent link">&para;</a></h2>
<h3 id="1a-essentialcore-labs">1A. Essential/Core Labs<a class="headerlink" href="#1a-essentialcore-labs" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Test</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
<th>Rationale</th>
<th>Target Finding</th>
</tr>
</thead>
<tbody>
<tr>
<td>CBC with differential</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">STAT</td>
<td>Baseline; infection markers; lymphopenia may be present</td>
<td>Normal or mild leukocytosis</td>
</tr>
<tr>
<td>CMP (BMP + LFTs)</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">STAT</td>
<td>Renal function for acyclovir dosing (nephrotoxic); electrolytes (SIADH); hepatic function</td>
<td>Normal; watch Na and Cr</td>
</tr>
<tr>
<td>Blood cultures x2</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">STAT</td>
<td>Exclude bacterial meningitis; concurrent bacteremia</td>
<td>No growth</td>
</tr>
<tr>
<td>Coagulation panel (PT/INR, aPTT)</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">STAT</td>
<td>Before LP; coagulopathy workup if DIC suspected</td>
<td>Normal</td>
</tr>
<tr>
<td>Blood glucose (paired with CSF)</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">STAT</td>
<td>CSF:serum glucose ratio interpretation</td>
<td>Document paired with LP</td>
</tr>
<tr>
<td>Procalcitonin</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">URGENT</td>
<td>Low procalcitonin argues against bacterial meningitis</td>
<td>Low (&lt;0.5 ng/mL favors viral)</td>
</tr>
<tr>
<td>CRP</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">URGENT</td>
<td>Inflammatory marker; lower in viral than bacterial</td>
<td>Mild elevation</td>
</tr>
<tr>
<td>Serum sodium</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">STAT</td>
<td>SIADH is common complication of HSV encephalitis</td>
<td>135-145 mEq/L; watch for hyponatremia</td>
</tr>
<tr>
<td>Serum osmolality</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">URGENT</td>
<td>SIADH evaluation</td>
<td>280-295 mOsm/kg</td>
</tr>
<tr>
<td>Type and screen</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">STAT</td>
<td>Potential surgical intervention for mass effect</td>
<td>On file</td>
</tr>
</tbody>
</table>
<h3 id="1b-extended-workup-second-line">1B. Extended Workup (Second-line)<a class="headerlink" href="#1b-extended-workup-second-line" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Test</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
<th>Rationale</th>
<th>Target Finding</th>
</tr>
</thead>
<tbody>
<tr>
<td>HSV-1/2 IgG and IgM (serum)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td>Seroconversion supports diagnosis; IgG positive in most adults (not diagnostic alone); IgM suggests acute infection</td>
<td>Rising titers on paired sera (acute + convalescent at 2-4 weeks)</td>
</tr>
<tr>
<td>HIV 1/2 antigen/antibody</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td>Immunocompromise affects prognosis and treatment duration</td>
<td>Document result</td>
</tr>
<tr>
<td>Urine osmolality and sodium</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td>SIADH confirmation (urine osm &gt;100, urine Na &gt;40 with low serum Na)</td>
<td>Evaluate if hyponatremic</td>
</tr>
<tr>
<td>TSH</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td>Thyroid dysfunction in encephalopathy differential</td>
<td>Normal</td>
</tr>
<tr>
<td>Ammonia</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">URGENT</td>
<td>Hepatic encephalopathy in differential</td>
<td>Normal</td>
</tr>
<tr>
<td>Troponin</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">URGENT</td>
<td>Stress cardiomyopathy; myocarditis in systemic viral illness</td>
<td>Normal</td>
</tr>
<tr>
<td>Toxicology screen (urine)</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">URGENT</td>
<td>Altered mental status differential</td>
<td>Negative</td>
</tr>
<tr>
<td>Blood alcohol level</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">URGENT</td>
<td>Altered mental status differential</td>
<td>Negative</td>
</tr>
</tbody>
</table>
<h3 id="1c-rarespecialized-refractory-or-atypical">1C. Rare/Specialized (Refractory or Atypical)<a class="headerlink" href="#1c-rarespecialized-refractory-or-atypical" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Test</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
<th>Rationale</th>
<th>Target Finding</th>
</tr>
</thead>
<tbody>
<tr>
<td>Autoimmune encephalitis panel (serum) — NMDAR, LGI1, CASPR2</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td>Post-HSV autoimmune encephalitis occurs in 20-27% (especially anti-NMDAR); also primary differential</td>
<td>Negative initially; recheck at 2-4 weeks if relapse</td>
</tr>
<tr>
<td>Paraneoplastic panel (serum)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
<td>If atypical features or oncologic history</td>
<td>Negative</td>
</tr>
<tr>
<td>VZV IgG/IgM (serum)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td>VZV encephalitis in differential (especially immunocompromised)</td>
<td>Negative</td>
</tr>
<tr>
<td>Arboviral serologies (West Nile, EEE, St. Louis)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
<td>Geographic/seasonal risk; summer-fall encephalitis</td>
<td>Negative</td>
</tr>
<tr>
<td>Rabies antibodies</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
<td>Animal exposure history with rapidly progressive encephalitis</td>
<td>Negative</td>
</tr>
<tr>
<td>Bartonella serology</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
<td>Cat exposure; neuroretinitis</td>
<td>Negative</td>
</tr>
</tbody>
</table>
<hr />
<h2 id="2-diagnostic-imaging-studies">2. DIAGNOSTIC IMAGING &amp; STUDIES<a class="headerlink" href="#2-diagnostic-imaging-studies" title="Permanent link">&para;</a></h2>
<h3 id="2a-essentialfirst-line">2A. Essential/First-line<a class="headerlink" href="#2a-essentialfirst-line" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Study</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
<th>Timing</th>
<th>Target Finding</th>
<th>Contraindications</th>
</tr>
</thead>
<tbody>
<tr>
<td>CT head without contrast</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">STAT</td>
<td>Immediate — before LP to exclude mass effect; CT may be NORMAL early in HSV encephalitis</td>
<td>Temporal lobe hypodensity, edema, hemorrhage (late); may be normal in first 48-72h</td>
<td>Pregnancy (relative)</td>
</tr>
<tr>
<td>MRI brain with and without contrast</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">STAT</td>
<td>Within 24h; STAT if available. MOST SENSITIVE imaging study — abnormal in &gt;90% within 48h</td>
<td>T2/FLAIR hyperintensity in medial temporal lobes (unilateral or bilateral), insular cortex, inferior frontal gyri, cingulate gyrus. DWI restriction in acute phase. Hemorrhagic transformation. Leptomeningeal enhancement</td>
<td>Pacemaker, metallic implants</td>
</tr>
<tr>
<td>EEG (routine or continuous)</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">STAT</td>
<td>Within 24h; continuous EEG if altered consciousness</td>
<td>Periodic lateralizing epileptiform discharges (PLEDs/LPDs) from temporal region — highly suggestive of HSV encephalitis; focal slowing; electrographic seizures; diffuse slowing</td>
<td>None significant</td>
</tr>
<tr>
<td>ECG (12-lead)</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">URGENT</td>
<td>On admission</td>
<td>Baseline; myocarditis screen; QTc for medication interactions</td>
<td>None</td>
</tr>
</tbody>
</table>
<h3 id="2b-extended">2B. Extended<a class="headerlink" href="#2b-extended" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Study</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
<th>Timing</th>
<th>Target Finding</th>
<th>Contraindications</th>
</tr>
</thead>
<tbody>
<tr>
<td>MRI brain with MRA/MRV</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td>If vascular complication suspected</td>
<td>Venous sinus thrombosis; vasculopathy; large vessel occlusion</td>
<td>Same as MRI</td>
</tr>
<tr>
<td>Repeat MRI brain</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td>At 48-72h if initial MRI negative but suspicion high; at 7-14 days to assess extent of damage</td>
<td>Evolving temporal changes; hemorrhagic transformation; extent of necrosis</td>
<td>Same as MRI</td>
</tr>
<tr>
<td>Continuous EEG (cEEG) monitoring</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">STAT</td>
<td>24-72h minimum if altered consciousness, seizures, or post-ictal state</td>
<td>Non-convulsive seizures, non-convulsive status epilepticus (NCSE), PLEDs</td>
<td>None</td>
</tr>
<tr>
<td>Chest X-ray</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">URGENT</td>
<td>On admission</td>
<td>Aspiration; baseline for ventilator management</td>
<td>None</td>
</tr>
</tbody>
</table>
<h3 id="2c-rarespecialized">2C. Rare/Specialized<a class="headerlink" href="#2c-rarespecialized" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Study</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
<th>Timing</th>
<th>Target Finding</th>
<th>Contraindications</th>
</tr>
</thead>
<tbody>
<tr>
<td>Brain biopsy</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td>Only if: PCR negative, MRI atypical, no response to acyclovir, alternative diagnosis likely</td>
<td>Cowdry type A inclusions; viral culture; PCR on tissue</td>
<td>Neurosurgical risk; coagulopathy</td>
</tr>
<tr>
<td>PET-CT brain</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
<td>If autoimmune encephalitis relapse suspected post-HSV</td>
<td>Mesial temporal hypermetabolism (seizure focus) or hypometabolism</td>
<td>Pregnancy</td>
</tr>
<tr>
<td>ICP monitoring (EVD)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">URGENT</td>
<td>If clinical signs of elevated ICP; declining GCS despite treatment</td>
<td>ICP &lt;22 mmHg; CPP &gt;60</td>
<td>Coagulopathy</td>
</tr>
</tbody>
</table>
<h3 id="lumbar-puncture">LUMBAR PUNCTURE<a class="headerlink" href="#lumbar-puncture" title="Permanent link">&para;</a></h3>
<p><strong>Indication:</strong> Diagnostic — ALL patients with suspected encephalitis. Do NOT delay acyclovir for LP.</p>
<p><strong>Timing:</strong> STAT. Start acyclovir BEFORE LP if any delay anticipated.</p>
<p><strong>Volume Required:</strong> 15-20 mL (extra for PCR, cytology, autoimmune panel)</p>
<table>
<thead>
<tr>
<th>Study</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th>Rationale</th>
<th>Target Finding</th>
</tr>
</thead>
<tbody>
<tr>
<td>Opening pressure</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td>Elevated in some cases; monitor for ICP issues</td>
<td>Normal or mildly elevated (usually &lt;300 mm H2O)</td>
</tr>
<tr>
<td>Cell count with differential (tubes 1 and 4)</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td>Lymphocytic pleocytosis typical; RBCs may be present (hemorrhagic encephalitis); tube comparison for traumatic tap</td>
<td>WBC 10-500 cells/µL (lymphocyte predominant); RBC may be elevated (hemorrhagic necrosis)</td>
</tr>
<tr>
<td>Protein</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td>Mildly to moderately elevated</td>
<td>Elevated (50-200 mg/dL typical; can be higher)</td>
</tr>
<tr>
<td>Glucose with paired serum</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td>Usually NORMAL in HSV (distinguishes from bacterial/TB/fungal)</td>
<td>Normal (&gt;60% serum glucose ratio); low glucose argues against HSV</td>
</tr>
<tr>
<td>HSV-1/2 PCR (CSF)</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td>GOLD STANDARD diagnostic test; sensitivity 96-98%, specificity ~99%. May be NEGATIVE in first 72h — if clinical suspicion high and initial PCR negative, REPEAT at 3-7 days</td>
<td>Positive (HSV-1 in &gt;90% adult cases; HSV-2 in neonatal/meningitis)</td>
</tr>
<tr>
<td>Gram stain and bacterial culture</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td>Exclude bacterial meningitis</td>
<td>No organisms</td>
</tr>
<tr>
<td>BioFire FilmArray ME Panel</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td>Rapid multiplex PCR — includes HSV-1/2, VZV, enterovirus, CMV, HHV-6, and bacterial pathogens; result in ~1 hour</td>
<td>HSV-1 detected (or other pathogen identified)</td>
</tr>
<tr>
<td>VZV PCR (CSF)</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td>VZV encephalitis in differential; especially immunocompromised and elderly</td>
<td>Negative (positive → VZV encephalitis — treat with IV acyclovir)</td>
</tr>
<tr>
<td>CMV PCR (CSF)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td>If immunocompromised (HIV/transplant)</td>
<td>Negative</td>
</tr>
<tr>
<td>EBV PCR (CSF)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td>If immunocompromised; CNS lymphoma differential</td>
<td>Negative</td>
</tr>
<tr>
<td>HHV-6 PCR (CSF)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td>Post-transplant encephalitis; temporal lobe involvement similar to HSV</td>
<td>Negative</td>
</tr>
<tr>
<td>Enterovirus PCR</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td>Viral meningitis differential</td>
<td>Negative</td>
</tr>
<tr>
<td>Autoimmune encephalitis panel (CSF) — NMDAR, LGI1, CASPR2, GABA-B</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td>Primary differential diagnosis; also detect post-HSV autoimmune encephalitis</td>
<td>Negative initially; recheck if relapse</td>
</tr>
<tr>
<td>Oligoclonal bands, IgG index</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td>Intrathecal antibody production; MS differential</td>
<td>May be positive (non-specific)</td>
</tr>
<tr>
<td>Cytology</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td>Exclude leptomeningeal malignancy</td>
<td>Negative</td>
</tr>
<tr>
<td>AFB smear and culture</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td>TB meningitis if subacute or basilar</td>
<td>Negative</td>
</tr>
<tr>
<td>VDRL (CSF)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td>Neurosyphilis screen</td>
<td>Negative</td>
</tr>
</tbody>
</table>
<p><strong>Special Handling:</strong> HSV PCR sample can be refrigerated; do NOT freeze. Process CSF rapidly for cell count. Save extra CSF (frozen at -80°C) for future studies if needed.</p>
<p><strong>Repeat LP indications:</strong> If initial HSV PCR negative but clinical suspicion high → repeat at 3-7 days. Also repeat if clinical deterioration at 2-4 weeks (relapse → send autoimmune encephalitis panel).</p>
<hr />
<h2 id="3-treatment">3. TREATMENT<a class="headerlink" href="#3-treatment" title="Permanent link">&para;</a></h2>
<h3 id="critical-start-acyclovir-immediately">⚠️ CRITICAL: START ACYCLOVIR IMMEDIATELY<a class="headerlink" href="#critical-start-acyclovir-immediately" title="Permanent link">&para;</a></h3>
<p><strong>Do NOT wait for LP, imaging, or PCR results. Every hour of delay increases mortality and morbidity. Start acyclovir on clinical suspicion alone.</strong></p>
<h3 id="3a-acuteemergent">3A. Acute/Emergent<a class="headerlink" href="#3a-acuteemergent" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Treatment</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
<th>Dosing</th>
<th>Contraindications</th>
<th>Monitoring</th>
</tr>
</thead>
<tbody>
<tr>
<td>Acyclovir IV</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">STAT</td>
<td>10 mg/kg IV q8h (infuse over 1h). Base on IDEAL body weight (IBW). Duration: minimum 14-21 days. Dose adjust for renal impairment: CrCl 25-50: 10 mg/kg q12h; CrCl 10-25: 10 mg/kg q24h; HD: 10 mg/kg after each dialysis session</td>
<td>True acyclovir allergy (extremely rare). Renal impairment — dose adjust, do NOT withhold</td>
<td>Renal function (BUN, Cr) daily; ensure adequate hydration (1-1.5 mL/kg/h IV fluids); urine output; acyclovir crystal nephropathy (maintain urine output); CBC (rare neutropenia); LFTs</td>
</tr>
<tr>
<td>IV normal saline (aggressive hydration)</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">STAT</td>
<td>1-1.5 mL/kg/h continuous to prevent acyclovir nephrotoxicity; bolus 500-1000 mL if dehydrated</td>
<td>Volume overload, CHF</td>
<td>I/O; Cr daily; urine output &gt;0.5 mL/kg/h</td>
</tr>
<tr>
<td>Empiric antibiotics (vancomycin + ceftriaxone)</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">STAT</td>
<td>Standard meningitis dosing. Continue until bacterial meningitis excluded by CSF results (Gram stain negative, BioFire negative, cultures negative at 48-72h). See Bacterial Meningitis template for dosing</td>
<td>See Bacterial Meningitis template</td>
<td>Standard</td>
</tr>
<tr>
<td>Dexamethasone</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">STAT</td>
<td>0.15 mg/kg IV q6h x 4 days — give empirically with antibiotics until bacterial meningitis excluded. Discontinue when bacterial excluded. Role in HSV encephalitis itself is CONTROVERSIAL — some evidence for reducing edema but no clear mortality benefit; not standard of care for isolated HSV</td>
<td>Uncontrolled infection (relative)</td>
<td>Glucose; GI prophylaxis</td>
</tr>
<tr>
<td>Levetiracetam (if seizures)</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">STAT</td>
<td>1000-1500 mg IV load; then 500-1000 mg IV/PO BID; max 3000 mg/day. Seizures occur in 40-60% of HSV encephalitis</td>
<td>Severe renal impairment (dose adjust)</td>
<td>Renal function; behavioral side effects</td>
</tr>
<tr>
<td>Lorazepam (seizure rescue)</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">STAT</td>
<td>0.1 mg/kg IV (max 4 mg); repeat x1 in 5 min if needed</td>
<td>Respiratory depression</td>
<td>RR, SpO2; airway equipment ready</td>
</tr>
<tr>
<td>Supplemental oxygen</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">STAT</td>
<td>If SpO2 &lt;94% or intubated</td>
<td>N/A</td>
<td>SpO2 target ≥94%</td>
</tr>
</tbody>
</table>
<h3 id="3b-symptomatic-treatments">3B. Symptomatic Treatments<a class="headerlink" href="#3b-symptomatic-treatments" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Treatment</th>
<th>Indication</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
<th>Dosing</th>
<th>Contraindications</th>
<th>Monitoring</th>
</tr>
</thead>
<tbody>
<tr>
<td>Acetaminophen</td>
<td>Fever (temperature goal &lt;38°C); headache</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">STAT</td>
<td>650-1000 mg PO/IV q6h; max 4g/day</td>
<td>Severe hepatic disease</td>
<td>Temperature; LFTs</td>
</tr>
<tr>
<td>Mannitol 20%</td>
<td>Cerebral edema / elevated ICP</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">STAT</td>
<td>1-1.5 g/kg IV bolus; then 0.25-0.5 g/kg q4-6h</td>
<td>Anuria</td>
<td>Serum osm &lt;320; renal function; I/O</td>
</tr>
<tr>
<td>Hypertonic saline 23.4%</td>
<td>Acute herniation</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">STAT</td>
<td>30 mL IV via central line over 10-20 min</td>
<td>No central access</td>
<td>Na (target 145-155); osmolality</td>
</tr>
<tr>
<td>Hypertonic saline 3% infusion</td>
<td>ICP management (less acute)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">STAT</td>
<td>0.5-1 mL/kg/h continuous; target Na 145-155</td>
<td>Hypernatremia</td>
<td>Na q4-6h; osmolality</td>
</tr>
<tr>
<td>Phenytoin/Fosphenytoin</td>
<td>Refractory seizures (second-line after levetiracetam)</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">STAT</td>
<td>Fosphenytoin 20 mg PE/kg IV at 150 mg PE/min; maintenance 100 mg PE q8h; target level 10-20 µg/mL</td>
<td>Bradycardia, heart block, hypotension (infusion rate-related)</td>
<td>Continuous telemetry during load; free phenytoin level; LFTs</td>
</tr>
<tr>
<td>Lacosamide</td>
<td>Seizure management (adjunctive)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td>200 mg IV/PO load; then 100-200 mg BID; max 400 mg/day</td>
<td>PR prolongation, AV block</td>
<td>ECG; PR interval</td>
</tr>
<tr>
<td>Ondansetron</td>
<td>Nausea/vomiting</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">STAT</td>
<td>4 mg IV/PO q6h PRN</td>
<td>QT prolongation</td>
<td>QTc</td>
</tr>
<tr>
<td>Pantoprazole</td>
<td>GI prophylaxis (if steroids or critical illness)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td>40 mg IV/PO daily</td>
<td>C. diff risk long-term</td>
<td>GI symptoms</td>
</tr>
<tr>
<td>Enoxaparin</td>
<td>DVT prophylaxis</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td>40 mg SC daily (start when not actively seizing and no hemorrhagic transformation)</td>
<td>Active bleeding, hemorrhagic transformation, coagulopathy, platelets &lt;50K</td>
<td>Platelets q3 days</td>
</tr>
<tr>
<td>Pneumatic compression devices</td>
<td>DVT prophylaxis</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">STAT</td>
<td>Apply bilaterally on admission</td>
<td>Acute DVT</td>
<td>Skin checks</td>
</tr>
<tr>
<td>Fluid restriction</td>
<td>SIADH management</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td>1-1.2 L/day if Na &lt;130 with clinical SIADH</td>
<td>Dehydration (balance with acyclovir hydration needs)</td>
<td>Na q6-8h; urine osm/Na; I/O</td>
</tr>
</tbody>
</table>
<h3 id="3c-second-linerefractory">3C. Second-line/Refractory<a class="headerlink" href="#3c-second-linerefractory" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Treatment</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
<th>Dosing</th>
<th>Contraindications</th>
<th>Monitoring</th>
</tr>
</thead>
<tbody>
<tr>
<td>Foscarnet IV (acyclovir-resistant HSV)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">EXT</td>
<td>60 mg/kg IV q8h or 90 mg/kg IV q12h; infuse over 1-2h with aggressive hydration. For proven or suspected acyclovir resistance (immunocompromised, HIV)</td>
<td>Renal failure (major nephrotoxin); electrolyte abnormalities</td>
<td>Cr daily; Ca, Mg, K, PO4 BID (causes severe electrolyte wasting); hydration 1-2 L NS before each dose</td>
</tr>
<tr>
<td>Decompressive craniectomy</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">STAT</td>
<td>For malignant cerebral edema with impending herniation, unresponsive to medical ICP management; consider if age appropriate and prognosis not already dismal</td>
<td>Bilateral massive necrosis; moribund patient</td>
<td>Post-op neuro checks; ICP monitoring; wound care</td>
</tr>
<tr>
<td>Immunotherapy for post-HSV autoimmune encephalitis</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">URGENT</td>
<td>If relapse at 2-6 weeks with new anti-NMDAR antibodies: IV methylprednisolone 1g/day x 5 days + IVIG 0.4 g/kg/day x 5 days; second-line: rituximab</td>
<td>Active HSV infection (ensure viral replication controlled)</td>
<td>NMDAR antibody titers; clinical response; viral PCR to confirm HSV not reactivated</td>
</tr>
</tbody>
</table>
<h3 id="3d-duration-of-treatment-and-discontinuation">3D. Duration of Treatment and Discontinuation<a class="headerlink" href="#3d-duration-of-treatment-and-discontinuation" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Scenario</th>
<th>Duration</th>
<th>Criteria to Stop</th>
</tr>
</thead>
<tbody>
<tr>
<td>Confirmed HSV encephalitis (PCR positive)</td>
<td>14-21 days IV acyclovir</td>
<td>Clinical improvement; repeat LP at end of treatment — if HSV PCR still positive, continue additional 7 days</td>
</tr>
<tr>
<td>Suspected HSV, PCR negative x2</td>
<td>Consider stopping at 7-10 days if: two negative HSV PCRs (initial + repeat at 3-7 days), MRI not consistent with HSV, alternative diagnosis established</td>
<td>Clinical stability; alternative diagnosis confirmed</td>
</tr>
<tr>
<td>Immunocompromised patients</td>
<td>21 days minimum</td>
<td>Repeat LP with PCR before stopping; ensure negative PCR before discontinuation</td>
</tr>
<tr>
<td>Transition to oral</td>
<td>Oral valacyclovir 1g PO TID x 3-6 months after IV course is INVESTIGATIONAL; some centers use for immunocompromised; not standard of care</td>
<td>Expert guidance</td>
</tr>
</tbody>
</table>
<hr />
<h2 id="4-other-recommendations">4. OTHER RECOMMENDATIONS<a class="headerlink" href="#4-other-recommendations" title="Permanent link">&para;</a></h2>
<h3 id="4a-referrals-consults">4A. Referrals &amp; Consults<a class="headerlink" href="#4a-referrals-consults" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Recommendation</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
<th>Indication</th>
</tr>
</thead>
<tbody>
<tr>
<td>Neurology consultation</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">STAT</td>
<td>All suspected encephalitis; seizure management; EEG interpretation; post-HSV autoimmune evaluation</td>
</tr>
<tr>
<td>Infectious disease consultation</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">STAT</td>
<td>Antimicrobial management; acyclovir-resistant HSV; duration of therapy</td>
</tr>
<tr>
<td>Neurosurgery consultation</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">STAT</td>
<td>Cerebral edema with mass effect; ICP monitoring (EVD placement); decompressive craniectomy</td>
</tr>
<tr>
<td>Critical care/ICU</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">STAT</td>
<td>Altered consciousness (GCS &lt;12); respiratory failure; ICP management; status epilepticus</td>
</tr>
<tr>
<td>Speech-language pathology (SLP)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">URGENT</td>
<td>Dysphagia evaluation; aphasia assessment (temporal lobe involvement); cognitive-communication evaluation</td>
</tr>
<tr>
<td>Physical therapy (PT)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">URGENT</td>
<td>Early mobilization; prevent deconditioning; gait/balance training</td>
</tr>
<tr>
<td>Occupational therapy (OT)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">URGENT</td>
<td>ADL assessment; cognitive rehabilitation; memory aids</td>
</tr>
<tr>
<td>Neuropsychology</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td>Cognitive assessment (memory deficits common with temporal lobe damage); rehabilitation planning</td>
</tr>
<tr>
<td>Psychiatry</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td>Behavioral changes; depression; anxiety; personality changes (frontal/temporal damage)</td>
</tr>
<tr>
<td>Rehabilitation medicine (physiatry)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td>Rehabilitation planning; disposition (inpatient rehab, SNF)</td>
</tr>
<tr>
<td>Social work</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td>Family support; discharge planning; long-term care needs</td>
</tr>
<tr>
<td>Epilepsy specialist</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td>Post-encephalitis epilepsy management; temporal lobe epilepsy</td>
</tr>
<tr>
<td>Palliative care</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td>Goals of care for severe cases; prognostication</td>
</tr>
</tbody>
</table>
<h3 id="4b-patient-instructions">4B. Patient Instructions<a class="headerlink" href="#4b-patient-instructions" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Recommendation</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
</tr>
</thead>
<tbody>
<tr>
<td>Return to ED if: new confusion, seizure, fever recurrence, worsening headache, personality change, speech difficulty, new weakness</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>HSV encephalitis can cause long-term memory and cognitive deficits; rehabilitation is important</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Seizures may develop weeks to months after infection; report any episodic symptoms (staring, jerking, déjà vu, loss of awareness)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Post-HSV autoimmune encephalitis can occur 2-6 weeks later with new psychiatric/neurologic symptoms — report immediately</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Take all medications as prescribed; do NOT stop antiepileptic drugs without neurologist guidance</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Follow-up with neurology in 2-4 weeks; neuropsychology testing at 3-6 months</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Cognitive rehabilitation and therapy are critical for recovery</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Driving restrictions until seizure-free per state law (typically 3-12 months)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
</tbody>
</table>
<h3 id="4c-lifestyle-prevention">4C. Lifestyle &amp; Prevention<a class="headerlink" href="#4c-lifestyle-prevention" title="Permanent link">&para;</a></h3>
<table>
<thead>
<tr>
<th>Recommendation</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
</tr>
</thead>
<tbody>
<tr>
<td>HSV encephalitis is NOT contagious in the traditional sense; no isolation needed</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Long-term suppressive antiviral therapy is NOT standard after encephalitis (unlike genital HSV)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Cognitive rehabilitation: memory strategies, organizational tools, speech therapy</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Seizure safety: avoid heights, swimming alone, operating heavy machinery until seizure-free</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Mental health support (depression, anxiety, PTSD common after encephalitis)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Adequate sleep and stress management</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
<tr>
<td>Gradual return to work/school with accommodations as needed</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
</tr>
</tbody>
</table>
<p>═══════════════════════════════════════════════════════════════
SECTION B: REFERENCE (Expand as Needed)
═══════════════════════════════════════════════════════════════</p>
<h2 id="5-differential-diagnosis">5. DIFFERENTIAL DIAGNOSIS<a class="headerlink" href="#5-differential-diagnosis" title="Permanent link">&para;</a></h2>
<table>
<thead>
<tr>
<th>Alternative Diagnosis</th>
<th>Key Distinguishing Features</th>
<th>Tests to Differentiate</th>
</tr>
</thead>
<tbody>
<tr>
<td>Autoimmune encephalitis (anti-NMDAR)</td>
<td>Subacute; psychiatric symptoms (psychosis, agitation); orofacial dyskinesias; seizures; young women; often post-HSV</td>
<td>Anti-NMDAR antibody (CSF &gt; serum); MRI may be normal or temporal; ovarian teratoma screen</td>
</tr>
<tr>
<td>Bacterial meningitis</td>
<td>Fever + meningismus; CSF neutrophilic pleocytosis with low glucose; more acute; no temporal preference on imaging</td>
<td>CSF Gram stain, culture, BioFire; procalcitonin elevated; CSF glucose low</td>
</tr>
<tr>
<td>Viral meningitis (enterovirus)</td>
<td>Headache + fever + meningismus; LESS confusion/focal deficits; CSF lymphocytic but fewer WBC; MRI normal</td>
<td>Enterovirus PCR (CSF); BioFire panel; normal MRI</td>
</tr>
<tr>
<td>VZV encephalitis</td>
<td>Immunocompromised; may have rash (but not always); vasculopathy pattern on MRI; cranial neuropathies</td>
<td>VZV PCR (CSF); VZV IgG intrathecal antibody</td>
</tr>
<tr>
<td>Temporal lobe seizures / Status epilepticus</td>
<td>Seizures may cause MRI signal change in temporal lobes mimicking encephalitis; fever if convulsive SE</td>
<td>EEG; HSV PCR negative; MRI DWI pattern; clinical course</td>
</tr>
<tr>
<td>Limbic encephalitis (paraneoplastic: LGI1, GABA-B)</td>
<td>Subacute memory loss, seizures, psychiatric changes; often &gt;40 years; associated malignancy</td>
<td>Antibody panel (serum + CSF); CT chest/abdomen/pelvis; PET-CT</td>
</tr>
<tr>
<td>Cerebral venous thrombosis</td>
<td>Headache, seizures, focal deficits; papilledema; risk factors (OCPs, hypercoagulable)</td>
<td>MRV; CT venogram; D-dimer</td>
</tr>
<tr>
<td>Brain abscess</td>
<td>Focal symptoms + fever; ring-enhancing lesion; subacute</td>
<td>MRI with contrast (ring enhancement, restricted DWI centrally); blood cultures</td>
</tr>
<tr>
<td>Acute disseminated encephalomyelitis (ADEM)</td>
<td>Post-infectious; multifocal white matter lesions; children &gt; adults</td>
<td>MRI (multifocal white matter); clinical context</td>
</tr>
<tr>
<td>Tuberculosis meningitis</td>
<td>Subacute (weeks); basilar meningitis; CSF low glucose, lymphocytic, very high protein</td>
<td>AFB culture; TB PCR; ADA; chest imaging</td>
</tr>
<tr>
<td>Neurosyphilis</td>
<td>Subacute; psychiatric symptoms; pupillary abnormalities; history of STI</td>
<td>CSF VDRL; FTA-ABS; RPR</td>
</tr>
<tr>
<td>Primary CNS lymphoma</td>
<td>Immunocompromised; progressive focal deficits; periventricular enhancing lesion</td>
<td>MRI with contrast; CSF cytology; EBV PCR (CSF); brain biopsy</td>
</tr>
</tbody>
</table>
<h2 id="6-monitoring-parameters">6. MONITORING PARAMETERS<a class="headerlink" href="#6-monitoring-parameters" title="Permanent link">&para;</a></h2>
<table>
<thead>
<tr>
<th>Parameter</th>
<th style="text-align: center;">ED</th>
<th style="text-align: center;">HOSP</th>
<th style="text-align: center;">OPD</th>
<th style="text-align: center;">ICU</th>
<th>Frequency</th>
<th>Target/Threshold</th>
<th>Action if Abnormal</th>
</tr>
</thead>
<tbody>
<tr>
<td>GCS / Neurologic exam</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">STAT</td>
<td>q1h x 24h, then q2h x 48h, then q4h</td>
<td>Improving or stable GCS</td>
<td>If declining: STAT CT; ICP assessment; consider EVD</td>
</tr>
<tr>
<td>Temperature</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">STAT</td>
<td>q4h (q1h if febrile)</td>
<td>&lt;38°C</td>
<td>Acetaminophen; cooling measures; reassess if persistent fever &gt;72h on acyclovir</td>
</tr>
<tr>
<td>Serum sodium</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">STAT</td>
<td>q6-8h x 48h, then q12h</td>
<td>135-145 mEq/L</td>
<td>If &lt;130: SIADH → fluid restriction (balance with acyclovir hydration); if &lt;120: 3% saline</td>
</tr>
<tr>
<td>Serum creatinine</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">STAT</td>
<td>Daily (twice daily if rising)</td>
<td>Stable; within normal</td>
<td>If rising: increase hydration; consider dose adjustment; hold if severe (rare); monitor urine output</td>
</tr>
<tr>
<td>BUN</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td>Daily</td>
<td>Normal</td>
<td>Dehydration; renal impairment</td>
</tr>
<tr>
<td>Urine output</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">STAT</td>
<td>q1h in ICU; q4h shift on floor</td>
<td>&gt;0.5 mL/kg/h (critical for acyclovir clearance)</td>
<td>Increase IV fluids; if oliguria: renal assessment</td>
</tr>
<tr>
<td>Seizure monitoring (EEG)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">URGENT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">STAT</td>
<td>cEEG 24-72h if altered consciousness; routine EEG daily if improving</td>
<td>No seizure activity</td>
<td>If seizures: load/adjust AEDs; if NCSE: aggressive treatment per SE protocol</td>
</tr>
<tr>
<td>Blood pressure</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">STAT</td>
<td>q1-4h based on severity</td>
<td>Stable; MAP &gt;60</td>
<td>Fluids; vasopressors if septic</td>
</tr>
<tr>
<td>Oxygen saturation</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">STAT</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">STAT</td>
<td>Continuous in ICU; q4h on floor</td>
<td>≥94%</td>
<td>Supplemental O2; intubation if respiratory failure</td>
</tr>
<tr>
<td>Repeat MRI brain</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td>At 48-72h (evolution); day 7-14 (extent of damage); 3-6 months (chronic changes)</td>
<td>Stable or improving</td>
<td>If worsening edema: ICP management; neurosurgery consult</td>
</tr>
<tr>
<td>Repeat LP (HSV PCR)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td>At end of treatment (day 14-21) to confirm PCR negativity; earlier if clinical suspicion of treatment failure</td>
<td>HSV PCR negative</td>
<td>If still positive: extend acyclovir 7+ more days; consider resistance</td>
</tr>
<tr>
<td>Autoimmune antibodies (follow-up)</td>
<td style="text-align: center;">-</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">ROUTINE</td>
<td style="text-align: center;">-</td>
<td>Recheck at 2-4 weeks if relapse or new psychiatric/neurologic symptoms</td>
<td>Negative</td>
<td>If positive (especially NMDAR): immunotherapy protocol</td>
</tr>
</tbody>
</table>
<h2 id="7-disposition-criteria">7. DISPOSITION CRITERIA<a class="headerlink" href="#7-disposition-criteria" title="Permanent link">&para;</a></h2>
<table>
<thead>
<tr>
<th>Disposition</th>
<th>Criteria</th>
</tr>
</thead>
<tbody>
<tr>
<td>Discharge home</td>
<td>NOT appropriate directly from ED for suspected HSV encephalitis — always admit. Discharge from hospital when: completing IV acyclovir course (or transitioned to monitoring); improved consciousness (GCS 15); no active seizures; stable neurologic exam; safe swallowing; rehabilitation arranged; follow-up confirmed</td>
</tr>
<tr>
<td>Admit to floor (monitored bed)</td>
<td>Mild encephalitis (GCS 13-15); stable; low seizure burden; able to cooperate with neuro checks</td>
</tr>
<tr>
<td>Admit to ICU / Neuro-ICU</td>
<td>GCS &lt;13; active seizures or status epilepticus; need for continuous EEG; respiratory compromise; signs of elevated ICP; hemodynamic instability</td>
</tr>
<tr>
<td>Transfer to higher level</td>
<td>Need for neuro-ICU not available; need for neurosurgery (decompressive craniectomy); continuous EEG not available</td>
</tr>
<tr>
<td>Inpatient rehabilitation</td>
<td>Moderate-severe cognitive deficits (memory impairment, aphasia); motor deficits; able to participate in 3h/day therapy</td>
</tr>
<tr>
<td>Skilled nursing facility</td>
<td>Unable to tolerate intensive rehabilitation; requires ongoing nursing care</td>
</tr>
</tbody>
</table>
<h2 id="8-evidence-references">8. EVIDENCE &amp; REFERENCES<a class="headerlink" href="#8-evidence-references" title="Permanent link">&para;</a></h2>
<table>
<thead>
<tr>
<th>Recommendation</th>
<th>Evidence Level</th>
<th>Source</th>
</tr>
</thead>
<tbody>
<tr>
<td>IV acyclovir 10 mg/kg q8h x 14-21 days</td>
<td>Class I, Level A</td>
<td>Whitley et al. (NEJM 1986) — acyclovir vs placebo landmark trial; reduced mortality from 70% to 20%</td>
</tr>
<tr>
<td>Start acyclovir empirically; do NOT delay for diagnostics</td>
<td>Class I, Level A</td>
<td>IDSA Encephalitis Guidelines (Tunkel et al. CID 2008); every hour of delay worsens outcomes</td>
</tr>
<tr>
<td>CSF HSV PCR as gold standard (sensitivity 96-98%)</td>
<td>Class I, Level A</td>
<td>Lakeman &amp; Whitley (JID 1995)</td>
</tr>
<tr>
<td>Repeat HSV PCR if initially negative with high clinical suspicion</td>
<td>Class I, Level B</td>
<td>False negative rate ~5% in first 72h; Roullet (2007)</td>
</tr>
<tr>
<td>MRI with DWI is most sensitive imaging</td>
<td>Class I, Level A</td>
<td>Sensitivity &gt;90% within 48h; temporal lobe predilection</td>
</tr>
<tr>
<td>EEG showing PLEDs supports diagnosis</td>
<td>Class IIa, Level B</td>
<td>Periodic lateralizing discharges in ~80% of HSV encephalitis</td>
</tr>
<tr>
<td>Post-HSV autoimmune encephalitis (anti-NMDAR) in 20-27%</td>
<td>Class IIa, Level B</td>
<td>Armangue et al. (Lancet Neurol 2014); Prüss et al. (Ann Neurol 2012)</td>
</tr>
<tr>
<td>Dexamethasone for HSV encephalitis: NOT standard of care</td>
<td>Class IIb, Level C</td>
<td>DexEnceph trial (ongoing); animal data supportive; no clear human mortality benefit</td>
</tr>
<tr>
<td>Foscarnet for acyclovir-resistant HSV</td>
<td>Class IIa, Level C</td>
<td>Expert consensus; primarily in immunocompromised</td>
</tr>
<tr>
<td>Aggressive hydration to prevent acyclovir nephrotoxicity</td>
<td>Class I, Level B</td>
<td>Well-established; crystal nephropathy prevention</td>
</tr>
<tr>
<td>Empiric bacterial coverage until excluded</td>
<td>Class I, Level A</td>
<td>Standard practice; cannot clinically distinguish bacterial meningitis from encephalitis at presentation</td>
</tr>
<tr>
<td>Repeat LP at end of treatment to confirm PCR negativity</td>
<td>Class IIa, Level C</td>
<td>Expert consensus; immunocompromised patients especially</td>
</tr>
<tr>
<td>14-day treatment minimum; 21 days for severe/immunocompromised</td>
<td>Class I, Level B</td>
<td>IDSA Guidelines; relapse rate higher with &lt;14 days</td>
</tr>
</tbody>
</table>
<hr />
<p><strong>APPENDIX: CLASSIC MRI FINDINGS IN HSV ENCEPHALITIS</strong></p>
<table>
<thead>
<tr>
<th>Feature</th>
<th>Description</th>
</tr>
</thead>
<tbody>
<tr>
<td>Location</td>
<td>Medial temporal lobes (hippocampus, amygdala), insular cortex, inferior frontal gyri, cingulate gyrus</td>
</tr>
<tr>
<td>Pattern</td>
<td>Unilateral initially; may become bilateral (asymmetric)</td>
</tr>
<tr>
<td>T2/FLAIR</td>
<td>Hyperintensity in affected regions</td>
</tr>
<tr>
<td>DWI</td>
<td>Restricted diffusion (bright on DWI, dark on ADC) in acute phase</td>
</tr>
<tr>
<td>Hemorrhage</td>
<td>SWI/GRE may show hemorrhagic necrosis (petechial or confluent)</td>
</tr>
<tr>
<td>Enhancement</td>
<td>Variable; leptomeningeal or cortical enhancement possible</td>
</tr>
<tr>
<td>Sparing</td>
<td>Typically spares basal ganglia and thalami (unlike autoimmune encephalitis which may involve these)</td>
</tr>
</tbody>
</table>
<p><strong>APPENDIX: POST-HSV AUTOIMMUNE ENCEPHALITIS</strong></p>
<table>
<thead>
<tr>
<th>Feature</th>
<th>Details</th>
</tr>
</thead>
<tbody>
<tr>
<td>Timing</td>
<td>2-6 weeks after HSV encephalitis (range 1 week to 3 months)</td>
</tr>
<tr>
<td>Prevalence</td>
<td>20-27% of HSV encephalitis cases</td>
</tr>
<tr>
<td>Antibody</td>
<td>Most commonly anti-NMDAR; less commonly others</td>
</tr>
<tr>
<td>Presentation</td>
<td>New psychiatric symptoms (psychosis, agitation), movement disorders (orofacial dyskinesias, choreoathetosis), seizures, autonomic instability, decreased consciousness</td>
</tr>
<tr>
<td>Diagnosis</td>
<td>Anti-NMDAR antibody in CSF; HSV PCR NEGATIVE (distinguishes from viral relapse)</td>
</tr>
<tr>
<td>Treatment</td>
<td>Immunotherapy: IV methylprednisolone + IVIG; second-line: rituximab; ensure HSV PCR negative before immunosuppression</td>
</tr>
<tr>
<td>Prognosis</td>
<td>Generally good with treatment; better than primary autoimmune encephalitis</td>
</tr>
</tbody>
</table>












                
              </article>
            </div>
          
          
<script>var target=document.getElementById(location.hash.slice(1));target&&target.name&&(target.checked=target.name.startsWith("__tabbed_"))</script>
        </div>
        
          <button type="button" class="md-top md-icon" data-md-component="top" hidden>
  
  <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24"><path d="M13 20h-2V8l-5.5 5.5-1.42-1.42L12 4.16l7.92 7.92-1.42 1.42L13 8z"/></svg>
  Back to top
</button>
        
      </main>
      
        <footer class="md-footer">
  
  <div class="md-footer-meta md-typeset">
    <div class="md-footer-meta__inner md-grid">
      <div class="md-copyright">
  
  
    Made with
    <a href="https://squidfunk.github.io/mkdocs-material/" target="_blank" rel="noopener">
      Material for MkDocs
    </a>
  
</div>
      
        
<div class="md-social">
  
    
    
    
    
      
      
    
    <a href="https://github.com/blondarb/neuro-plans" target="_blank" rel="noopener" title="github.com" class="md-social__link">
      <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Free 7.1.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2025 Fonticons, Inc.--><path d="M173.9 397.4c0 2-2.3 3.6-5.2 3.6-3.3.3-5.6-1.3-5.6-3.6 0-2 2.3-3.6 5.2-3.6 3-.3 5.6 1.3 5.6 3.6m-31.1-4.5c-.7 2 1.3 4.3 4.3 4.9 2.6 1 5.6 0 6.2-2s-1.3-4.3-4.3-5.2c-2.6-.7-5.5.3-6.2 2.3m44.2-1.7c-2.9.7-4.9 2.6-4.6 4.9.3 2 2.9 3.3 5.9 2.6 2.9-.7 4.9-2.6 4.6-4.6-.3-1.9-3-3.2-5.9-2.9M252.8 8C114.1 8 8 113.3 8 252c0 110.9 69.8 205.8 169.5 239.2 12.8 2.3 17.3-5.6 17.3-12.1 0-6.2-.3-40.4-.3-61.4 0 0-70 15-84.7-29.8 0 0-11.4-29.1-27.8-36.6 0 0-22.9-15.7 1.6-15.4 0 0 24.9 2 38.6 25.8 21.9 38.6 58.6 27.5 72.9 20.9 2.3-16 8.8-27.1 16-33.7-55.9-6.2-112.3-14.3-112.3-110.5 0-27.5 7.6-41.3 23.6-58.9-2.6-6.5-11.1-33.3 2.6-67.9 20.9-6.5 69 27 69 27 20-5.6 41.5-8.5 62.8-8.5s42.8 2.9 62.8 8.5c0 0 48.1-33.6 69-27 13.7 34.7 5.2 61.4 2.6 67.9 16 17.7 25.8 31.5 25.8 58.9 0 96.5-58.9 104.2-114.8 110.5 9.2 7.9 17 22.9 17 46.4 0 33.7-.3 75.4-.3 83.6 0 6.5 4.6 14.4 17.3 12.1C436.2 457.8 504 362.9 504 252 504 113.3 391.5 8 252.8 8M105.2 352.9c-1.3 1-1 3.3.7 5.2 1.6 1.6 3.9 2.3 5.2 1 1.3-1 1-3.3-.7-5.2-1.6-1.6-3.9-2.3-5.2-1m-10.8-8.1c-.7 1.3.3 2.9 2.3 3.9 1.6 1 3.6.7 4.3-.7.7-1.3-.3-2.9-2.3-3.9-2-.6-3.6-.3-4.3.7m32.4 35.6c-1.6 1.3-1 4.3 1.3 6.2 2.3 2.3 5.2 2.6 6.5 1 1.3-1.3.7-4.3-1.3-6.2-2.2-2.3-5.2-2.6-6.5-1m-11.4-14.7c-1.6 1-1.6 3.6 0 5.9s4.3 3.3 5.6 2.3c1.6-1.3 1.6-3.9 0-6.2-1.4-2.3-4-3.3-5.6-2"/></svg>
    </a>
  
</div>
      
    </div>
  </div>
</footer>
      
    </div>
    <div class="md-dialog" data-md-component="dialog">
      <div class="md-dialog__inner md-typeset"></div>
    </div>
    
    
    
      
      
      <script id="__config" type="application/json">{"annotate": null, "base": "../..", "features": ["navigation.instant", "navigation.tracking", "navigation.sections", "navigation.expand", "navigation.top", "search.suggest", "search.highlight", "content.code.copy"], "search": "../../assets/javascripts/workers/search.2c215733.min.js", "tags": null, "translations": {"clipboard.copied": "Copied to clipboard", "clipboard.copy": "Copy to clipboard", "search.result.more.one": "1 more on this page", "search.result.more.other": "# more on this page", "search.result.none": "No matching documents", "search.result.one": "1 matching document", "search.result.other": "# matching documents", "search.result.placeholder": "Type to start searching", "search.result.term.missing": "Missing", "select.version": "Select version"}, "version": null}</script>
    
    
      <script src="../../assets/javascripts/bundle.79ae519e.min.js"></script>
      
        <script src="../../assets/js/comments.js"></script>
      
    
  </body>
</html>